Century Therapeutics

Develops engineered cell therapies for cancer and autoimmune diseases.

Discussion
BiotechnologyPharmaceuticals
centurytx.com ↗ LinkedIn ↗

Company facts

Founded
2018
Employees
150
Headquarters
United States
Type
Public
Listed
NASDAQ: IPSC
Subsidiaries
Clade, Empirica Therapeutics

About

Century Therapeutics is a biotechnology firm focused on developing an industry‑leading, allogeneic cell therapy platform based on induced pluripotent stem cells (iPSC). Leveraging advanced gene editing, protein engineering, and robust manufacturing capabilities, the company creates off‑the‑shelf iPSC‑derived therapies aimed at treating autoimmune diseases and cancer. By integrating cutting‑edge scientific techniques with scalable production, Century Therapeutics delivers innovative, high‑precision cellular medicines that address unmet medical needs.